Prototype of running clinical trials in an untrustworthy environment using blockchain

Blockchain adoption has been posited to have positive connotations in clinical trial management, DNA data transmission, remote patient monitoring, drug discovery, biomarker development, and preventive healthcare.

“For example, blockchain adoption has been posited to have positive connotations in clinical trial management (Wong et al., 2019), DNA data transmission (S.J. Lee et al., 2018), remote patient monitoring (Griggs et al., 2018;Dwivedi et al., 2019) as well as drug discovery, biomarker development, and preventive healthcare (Mamoshina et al., 2018).”

Studies have focused on improving processes for timely updates and reporting for adverse events.

“Additionally, prior studies have focused on improving processes for timely updates (Wang & Song, 2018) and reporting for adverse events (Wong et al., 2019).”

Societal constraints include possibility of collusion for fabricating data and inability to control clinical malpractice.

“For example, there may be a possibility of collusion for fabricating data (Wong et al., 2019) or a healthcare system may be constrained by an inability to control clinical malpractice (Zhang et al., 2018)”

Certain studies pointed to socially-oriented concerns about public data sharing and users' trust in governments.

“However, certain studies have also pointed to more sociallyoriented concerns about public data sharing (Wong et al., 2019) and users' trust in governments (Dhagarra et al., 2019).”

Researchers have called for extending technical boundaries of framework development to improve scalability and functionality.

“Further, in order to improve the scalability (Zhang et al., 2016) and functionality (Wong et al., 2019) of previously proposed frameworks, researchers have called for the need to extend the current technical boundaries of framework development, e.g. by consideration of novel blockchain platforms (Rahmadika & Rhee, 2019).”